Fractionation in adjuvant radiotherapy for invasive breast cancer and ductal carcinoma in situ in Ontario, Canada from 2009 to 2015 [0.03%]
2009年至2015年加拿大安大略省乳腺癌和导管原位癌辅助放疗的分割剂量模式分析
Stephanie Chan,Rinku Sutradhar,Zhan Yao et al.
Stephanie Chan et al.
The use of hypofractionated radiotherapy (HFRT) in patients with breast cancer and ductal carcinoma in situ (DCIS) in Ontario, Canada, from 2009 to 2015 was reported. A retrospective cohort study was conducted using data from the Institute ...
Reply-To Letter to the Editor; Prospective evaluation of the limitations of near-infrared imaging in detecting axillary sentinel lymph nodes in primary breast cancer [0.03%]
致编辑的回信；前瞻性评估近红外线影像在检测原发性乳腺癌腋窝哨兵淋巴结限制因素的影响
Chafika Mazouni,Angelica Conversano,Corinne Laplace-Builhé et al.
Chafika Mazouni et al.
Sewing needles in the breasts localized intraoperatively with sentimag probe [0.03%]
术中使用Sentimag探针定位乳腺缝合针
Andrea M Winter,Debbie L Bennett,Theresa Schwartz
Andrea M Winter
Apparent diffusion coefficient: Potential biomarker for complete response after neo-adjuvant chemotherapy in breast cancer [0.03%]
弥散系数的潜在生物标志物：乳腺癌新辅助化疗后完全缓解患者的表征
Lucia Graña-López,Michel Herranz,Fiz Andrés Maciñeira et al.
Lucia Graña-López et al.
Detection of JAK2 gene mutation in Pakistani women with triple-negative breast cancer [0.03%]
检测三阴性乳腺癌巴基斯坦妇女JAK2基因突变
Mohammad Abdul Naeem,Tayyab Hussain Shah,Nadeem Zafar et al.
Mohammad Abdul Naeem et al.
Acellular dermal matrices safety in breast reconstruction-Is it truly associated with higher rates of complications? A large single-surgeon cohort analysis [0.03%]
脱细胞基质在乳房重建中的安全性--真的与较高的并发症发生率有关吗？一项大规模的单外科医生队列分析
Ines Vasconcelos,Friederike Siedentopf,Winfried Schoenegg
Ines Vasconcelos
Time to initiation of neo-adjuvant chemotherapy for breast cancer treatment does not influence patient survival: A study of US breast cancer patients [0.03%]
乳腺癌治疗开始新辅助化疗的时间不影响患者生存率：一项关于美国乳腺癌患者的调查研究
Devon Livingston-Rosanoff,Bret Hanlon,Nicholas Marka et al.
Devon Livingston-Rosanoff et al.
Delays in the initiation of adjuvant chemotherapy or radiation therapy are associated with worse outcomes in patients undergoing treatment for breast cancer. However, the impact of the time to initiation of neo-adjuvant chemotherapy (NAC) o...
Maha Abdel Hadi,Afnan Al Muhanna,Jumana Alratroot et al.
Maha Abdel Hadi et al.
Case Reports
The breast journal. 2020 Feb;26(2):295-296. DOI:10.1111/tbj.13553 2020
Primary neuroendocrine carcinoma of the breast: A case report of liver and lymph node metastases after eight years from diagnosis [0.03%]
原发性乳腺类癌一例八年远处转移后再就诊报告
Irene Valente,Giulia Tringali,Eugenia Marta Martella et al.
Irene Valente et al.
Primary neuroendocrine carcinoma of the breast (NECB) is one of the rarest subtypes of breast tumor, and for this reason, there are no data from prospective clinical trials on its optimal management. Its incidence is
Case Reports
The breast journal. 2020 Mar;26(3):505-507. DOI:10.1111/tbj.13535 2020
Cole Billena,Atif J Khan,Oren Cahlon et al.
Cole Billena et al.